Lyytinen and colleagues from Helsinki reported the results of a cohort study assessing the risk of breast cancer in postmenopausal Finnish women using oral, transdermal, and vaginal estrogen products containing either estradiol or estriol.
Lacey and colleagues from the National Cancer Institute reported the results of postmenopausal hormone exposure in a cohort study with 214 cases of ovarian cancer.1 The over-all cohort of 97,368 women constituted the NIH-AARP Diet and Health Study.
Drug Labels A Prescription for Misunderstanding?; Osteonecrosis of the Jaw New Side-Effect to Bisphosphate Use; Beta-Blockers and Depression Unlinked?; FDA Actions
Kahlenborn and colleagues performed a meta-analysis of case-control studies published after 1979 that focused on the use of oral contraceptives and the risk of premenopausal breast cancer.
The resection of tumor nodules (or cytoreduction) before primary chemotherapy has been linked closely with survival in patients with advanced epithelial ovarian cancer. Chi and colleagues set out to evaluate the merits of cytoreduction completeness in a homogeneous cohort of ovarian cancer patients with bulky metastatic disease.
The lead paper in the November issue of Obstetrics and Gynecology should stimulate lively discussion regarding the counseling of patients of advanced maternal age (AMA), and, if taken at face value, could impact the field of prenatal diagnosis, in general.
Brown D. Increased urinary lignan excretion association with decreased risk of uterine fibroids. Altern Ther Women's Health 2007;9(1):7-8.
Marcolina ST, Fenstemacher PA. Optimizing oral health in women: More than just lip service. Part 2 of a series on oral health. Altern Ther Women's Health 2007;9(1):1-7.
